Nutraplus India Ltd has finalized a 3.5-acre plot in South Gujarat for the installation of a Compressed Biogas (CBG) plant, marking a significant step in its expansion into renewable energy infrastructure. The facility will be established on a lease basis, with the company currently in advanced negotiations to award the turnkey installation contract to engineering, procurement, and construction (EPC) specialist Biofics. This development signals Nutraplus’s strategic pivot toward waste-to-energy solutions, capitalizing on the abundant availability of raw materials such as municipal waste, agro-waste, forest waste, sugar cane waste, and animal husbandry and cattle waste in the region.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III thereof. The filing, submitted to the Bombay Stock Exchange Ltd on August 03, 2026, confirms that the selection of the site and the engagement with Biofics are part of a structured rollout plan. Mukesh Naik, Managing Director of Nutraplus India Ltd, signed the communication, underscoring management’s commitment to executing the project through a reliable EPC partner.

Project Details and Partners

The core of this initiative involves the collaboration with Biofics for the end-to-end setup of the CBG plant. By opting for a turnkey contract, Nutraplus aims to streamline the deployment process, reducing execution risks and accelerating time-to-market. The choice of South Gujarat as the location is strategic, given the region’s agricultural output and waste generation patterns, which ensure a consistent supply of feedstock.

Feedstock Availability

A critical success factor for any CBG plant is the consistency and cost-efficiency of its feedstock. Nutraplus highlighted that the key raw materials—municipal waste, agro-waste, forest waste, sugar cane waste, and animal husbandry and cattle waste—are readily available in the vicinity. This proximity reduces logistics costs and ensures operational continuity, addressing one of the primary challenges in the biogas sector: supply chain volatility.

What the Numbers Show

While financial metrics such as project cost or expected revenue were not disclosed in this filing, the strategic alignment of land acquisition, EPC partnership, and feedstock security presents a low-risk entry model for Nutraplus. The decision to lease the 3.5-acre plot rather than purchase it suggests a capital-light approach, preserving liquidity for other operational needs. Furthermore, engaging Biofics for turnkey installation indicates a focus on speed and technical reliability over in-house construction capabilities, which may reduce initial capex exposure but ties performance outcomes to the contractor’s efficiency.

The move positions Nutraplus India Ltd to capitalize on government incentives for compressed biogas production under the SATAT scheme, although specific regulatory benefits were not detailed in the disclosure. Investors should monitor subsequent filings for updates on contract award dates, commissioning timelines, and capacity specifications of the new plant.

Nutraplus India Limited reported a net loss of ₹2.14 lakh for the quarter ended March 31, 2025, as the company continued to record zero revenue from operations. The total expenditure for the quarter stood at ₹2.14 lakh, driven primarily by other expenses of ₹3.37 lakh and employee benefit expenses of ₹0.24 lakh. For the full fiscal year ended March 31, 2025, the company posted a net loss of ₹5.01 lakh on a total income of ₹0.10 lakh.

The Board of Directors approved the Unaudited Standalone Financial Results for the quarter and year ended March 31, 2025, at a meeting held on July 15, 2025. The results were reviewed by the Audit Committee and subsequently approved by the Board. The company operates in a single segment, Active Pharmaceutical Ingredient (API).

Financial Performance

The financial statements reveal a challenging period with no operational revenue. The company's earnings per equity share of face value ₹5 each was reported at (₹0.01) for the quarter and (₹0.01) for the year ended March 31, 2025.

Auditor's Qualification

Raman S. Shah & Associates, Statutory Auditors, issued a qualified opinion on the standalone financial results. The qualification arises because the company did not comply with the listing requirements under the Companies Act, 2013, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically regarding the submission of its limited review report and quarterly financial results within the prescribed timelines.

The auditors stated that such non-compliance is material in the context of timely and reliable financial reporting for listed entities. The company noted in its disclosures that it lost key employees across finance, accounts, legal, production, and marketing departments after business activities ceased following FY 2019-20, contributing to the inability to meet regulatory compliance timelines.

Balance Sheet Position

As of March 31, 2025, the company's total assets stood at ₹516.23 lakh, comprising mainly of current assets of ₹516.21 lakh. The equity section showed a negative balance of ₹535.01 lakh. Total liabilities amounted to ₹1,051.24 lakh, with current liabilities of ₹872.70 lakh and non-current liabilities of ₹178.54 lakh.